This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Charles Vogel, MD; Donald W. Paty, MD; Robert F. Kibler, MD

Arch Neurol. 1972;26(4):366-373.

Abstract
A comparison of the effectiveness of methylprednisolone sodium succinate and cyclophosphamide in the short-term treatment of experimental allergic encephalomyelitis has been made in the rabbit. Both drugs proved to be effective. At a dosage of 5 mg/kg/day cyclophosphamide did not alter the clinical course of the disease but did significantly reduce the severity of the histological changes. At 20 mg/kg/day, it had a beneficial effect on both features of the disease. Methylprednisolone appeared to act more rapidly than cyclophosphamide. Side effects of either drug were minimal. Long-term treatment of the disease, judged on the clinical course alone, was achieved for periods of three to four weeks with an intermittent regimen of methylprednisolone administration without serious side effects.

Author Affiliations
Atlanta

From the Department of Medicine (Neurology), Emory University School of Medicine, Atlanta. Dr. Vogel is now with the Uganda Cancer Institute, and Dr. Paty is now with the Medical Research Council, University of Newcastle-Upon-Tyne, England.

Footnotes
Accepted for publication Nov 5, 1971.

Reprint requests to the Glenn Memorial Bldg, 69 Butler St, Atlanta 30303 (Dr. Kibler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?